Preoperative gastric ultrasonography could have identified retained gastric material, allowing more accurate risk stratification and adoption of additional preventive measures
Tirzepatide weight loss data (SURMOUNT trials) The SURMOUNT-1 trial changed the conversation about what was possible with pharmacological weight management
The co-expression of FOXP3 and glucocorticoid receptor (GR) was increased after TAT-GILZ treatment
HOW TO CHOOSE THE RIGHT OZEMPIC ALTERNATIVE FOR YOU Its always best to choose an approach that aligns with your health needs, safety concerns, individual preferences, and long-term wellness goals
Factors affecting treatment outcomes Despite the existing, wide inter-individual variability in the concentrations of tamoxifen and its metabolites, there was no evidence linking variability in tamoxifen or its metabolite concentrations with patient response or side effects
GLP-1 Receptor Agonists as a Novel Solution for Antipsychotic-Induced Weight Gain in Severe and Persistent Mental Illness